Eriko Yanagida

Deep learning shows the capability of high-level computer-aided diagnosis in malignant lymphoma

Hiroaki Miyoshi, Kensaku Sato, Yoshinori Kabeya et al. · Laboratory Investigation · 2020 · 88 citations

Medicine, Computer Science, Oncology +13

Epidemiology and secular trends of malignant lymphoma in Japan: Analysis of 9426 cases according to the World Health Organization classification

Reiji Muto, Hiroaki Miyoshi, Kensaku Sato et al. · Cancer Medicine · 2018 · 71 citations · Full text

Medicine, Hematology, Oncology +13

Frequent expression of <scp>CD</scp>30 in extranodal <scp>NK</scp>/<scp>T</scp>‐cell lymphoma: Potential therapeutic target for anti‐<scp>CD</scp>30 antibody‐based therapy

Keisuke Kawamoto, Hiroaki Miyoshi, Takaharu Suzuki et al. · Hematological Oncology · 2017 · 37 citations

Medicine, Immunology, Oncology +12

Combination of CD47 and signal‐regulatory protein‐α constituting the “don’t eat me signal” is a prognostic factor in diffuse large B‐cell lymphoma

Ryo Kazama, Hiroaki Miyoshi, Mai Takeuchi et al. · Cancer Science · 2020 · 37 citations · Full text

Medicine, Oncology, Pathology +17

Prognostic factors for histiocytic and dendritic cell neoplasms

Joji Shimono, Hiroaki Miyoshi, Fumiko Arakawa et al. · Oncotarget · 2017 · 30 citations · Full text

Veterinary Medicine, Oncology, Pathology +16